SageMedic Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
SageMedic General Information
Description
Developer of a three-dimensional micro-tumor assay designed to guide cancer therapy for proper patient outcomes. The company collects patients' tumor samples, creates micro-tumors, identifies the best treatment for cancer patients that overcomes the inherent limitations of genomic testing, treats them with approved drugs, and measures the response to identify effective treatment, enabling physicians to determine the cancer treatment for their patients and treat them to a healthy life.
Contact Information
Website
www.sagemedic.comCorporate Office
- 555 Twin Dolphin Drive
- Suite 110
- Redwood City, CA 94065
- United States
Corporate Office
- 555 Twin Dolphin Drive
- Suite 110
- Redwood City, CA 94065
- United States
SageMedic Timeline
SageMedic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-May-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Apr-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-Dec-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 31-Dec-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 14-Dec-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 18-Jul-2019 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Aug-2018 | $6M | $6M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SageMedic Patents
SageMedic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4555317-A1 | A high-throughput multiplexed viability and proliferation assay | Pending | 15-Jun-2022 | ||
| EP-4555317-A4 | A high-throughput multiplexed viability and proliferation assay | Pending | 15-Jun-2022 | ||
| WO-2023244699-A1 | A high-throughput multiplexed viability and proliferation assay | Inactive | 15-Jun-2022 | ||
| US-12312631-B1 | High-throughput multiplexed sensitivity and resistance assay | Active | 15-Jun-2022 | ||
| EP-3864140-A1 | Analysis of viable and nonviable cells | Active | 12-Oct-2018 | G01N15/1434 |
SageMedic Signals
SageMedic Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cowtown Angels | Angel Group | Minority | ||
| Denniston Family Office | Family Office | Minority | ||
| Harlem River Navy | Family Office | Minority | ||
| Angel (individual) | Minority | |||
| Keiretsu Forum | Angel Group | Minority |
SageMedic FAQs
-
When was SageMedic founded?
SageMedic was founded in 2012.
-
Where is SageMedic headquartered?
SageMedic is headquartered in Redwood City, CA.
-
What is the size of SageMedic?
SageMedic has 10 total employees.
-
What industry is SageMedic in?
SageMedic’s primary industry is Therapeutic Devices.
-
Is SageMedic a private or public company?
SageMedic is a Private company.
-
What is SageMedic’s current revenue?
The current revenue for SageMedic is .
-
How much funding has SageMedic raised over time?
SageMedic has raised $8.22M.
-
Who are SageMedic’s investors?
Cowtown Angels, Denniston Family Office, Harlem River Navy, , and Keiretsu Forum are 5 of 10 investors who have invested in SageMedic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process